AI Drug Discovery Passed Its First Real Clinical Test
The first molecules designed end-to-end by AI have entered the clinic. Early results vindicate the hype — partly.
0 reactions · anonymous
Designed in silico, validated in vivo
AI-generated candidates now routinely compress the discovery phase from four years to eighteen months, hitting binding targets that traditional screens missed.
The honest caveat: discovery was never the binding constraint. Clinical trials still eat a decade. AI's win is making failures cheaper and faster.
Building incoffeed — a daily editorial on tech, AI, fintech and business. Co-founder & editor.
Discussion
0// No comments yet — be the first to start the discussion.
